Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 11.74% is 85% above its 5-year average of 6.33%, near the high end of its 5-year range (2.79%–15.53%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.41% above its 12-month average of 11.25%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
11.74%
DEBT TO ASSETS RATIO AVG TTM
11.25%
DEBT TO ASSETS RATIO AVG 3Y
8.54%
DEBT TO ASSETS RATIO AVG 5Y
6.33%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.41%
CURRENT VS 3Y AVG
+37.52%
CURRENT VS 5Y AVG
+85.48%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.28%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+4093.44%
vs the sector median at left
Moderna, Inc.
Market Cap
$56.28B
Debt to Assets Ratio
11.74%
TTM Avg
11.25%
3Y Avg
8.54%
5Y Avg
6.33%
Market Cap
$56.43B
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.08B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$49.58B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$66.98B
Debt to Assets Ratio
0.28%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.89B
Debt to Assets Ratio
0.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $56.28B | 11.74% | 11.25% | 8.54% | 6.33% |
| Cardinal Health, Inc. (CAH)vs › | $56.43B | 0.17% | N/A | N/A | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $50.08B | 0.05% | N/A | N/A | N/A |
| Becton, Dickinson and Company (BDX)vs › | $49.58B | 0.33% | N/A | N/A | N/A |
| Cencora, Inc. (COR)vs › | $63.65B | 0.14% | N/A | N/A | N/A |
| Humana Inc. (HUM)vs › | $48.71B | 0.25% | N/A | N/A | N/A |
| Boston Scientific Corporation (BSX)vs › | $66.98B | 0.28% | N/A | N/A | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $43.08B | 0.54% | N/A | N/A | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.89B | 0.42% | N/A | N/A | N/A |
| Agilent Technologies, Inc. (A)vs › | $41.67B | 0.28% | N/A | N/A | N/A |
Debt/Assets
11.7%
Debt/Equity
0.19
Current Ratio
2.29
Interest Coverage
-307.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 11.74% |
| 2026-03-31 | 11.30% |
| 2025-12-31 | 15.53% |
| 2025-09-30 | 11.49% |
| 2025-06-30 | 6.17% |
| 2025-03-31 | 5.86% |
| 2024-12-31 | 5.28% |
| 2024-09-30 | 8.57% |
| 2024-06-30 | 8.09% |
| 2024-03-31 | 7.39% |
| 2023-12-31 | 6.75% |
| 2023-09-30 | 7.48% |
| 2023-06-30 | 5.34% |
| 2023-03-31 | 4.59% |
| 2022-12-31 | 4.64% |
| 2022-09-30 | 4.84% |
| 2022-06-30 | 3.41% |
| 2022-03-31 | 3.43% |
| 2021-12-31 | 3.71% |
| 2021-09-30 | 2.79% |
| 2021-06-30 | 3.73% |
| 2021-03-31 | 2.25% |
| 2020-12-31 | 3.23% |
| 2020-09-30 | 4.56% |
| 2020-06-30 | 4.81% |
| 2020-03-31 | 7.15% |
| 2019-12-31 | 8.33% |
| 2019-09-30 | 2.12% |
| 2019-06-30 | 1.99% |
| 2019-03-31 | 1.85% |
| 2018-12-31 | 1.71% |
| 2018-09-30 | 1.81% |
| 2018-06-30 | 1.67% |
| 2017-12-31 | 1.45% |
